Anti-Cancer Effect of IN-2001 in MDA-MB-231 Human Breast Cancer
In recent years, inhibition of HDACs has emerged as a potential strategy to reverse aberrant epigenetic changes associated with cancer, and several classes of HDAC inhibitors have been found to have potent and specific anticancer activities in preclinical studies. But their precise mechanism of acti...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Korean Society of Applied Pharmacology
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794529/ |